Results 61 to 70 of about 4,450 (159)
[Heterogeneity analysis of pancreatic cancer and identification of molecular subtypes of tumor cells based on CEACAM5, LGALS1 and CENPF gene expression]. [PDF]
Nan Fang Yi Ke Da Xue Xue Bao, 2023 Sun J, Lu P, Guan S, Liu S.
europepmc +1 more source
Interpretation of 2023 2nd NCCN clinical practice guidelines in oncology-pancreatic adenocarcinoma [PDF]
Pancreatic adenocarcinoma, a severe digestive malignancy, is characterized by its poor prognosis. The National Comprehensive Cancer Network (NCCN) persistently refines its guidelines, integrating cutting-edge evidence-based medical insights to ...
CHEN Jiahao, JIANG Chongyi
core +1 more source
Zhongguo shiyan zhenduanxue, 2013 目的探讨miRNA在胰腺癌患者血浆中的表达及临床意义。方法比较40例胰腺癌患者（观察组）及40例正常志愿者（对照组）血浆中的4种miRNA（miR-190、miR-196a、miR-221和miR-222）水平,并分析其与患者年龄、性别、肿瘤部位、分化程度及CA199水平的关系。结果胰腺癌患者血浆中4种miRNA表达量的水平较对照组均明显升高,差异有统计学意义 ...
牛海刚
doaj
[Multi-tissue segmentation model of whole slide image of pancreatic cancer based on multi task and attention mechanism]. [PDF]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2023 Gao W, Jiang H, Jiao Y, Wang X, Xu J.
europepmc +1 more source
[18F]F-FMISO and [18F]F-FLT PET/CT dual-nuclide imaging for in vivo prediction of drug resistance in pancreatic cancer [PDF]
Objective·[18F]F-FMISO and [18F]F-FLT are specific PET imaging agents for detecting the hypoxia microenvironment and cell proliferation, respectively.
HAI Wangxi, QU Qian, SUN Chenwei, XI Yun
core +1 more source
Zhongguo shiyan zhenduanxue, 2016 胰腺癌（pancreatic20carcinoma,PC）是消化系统中恶性程度最高、预后最差的恶性肿瘤之一,95%的胰腺癌为胰腺导管腺癌（pancreatic20ductule20adenocarcinoma,PDAC）,其发病率有不断上升趋势。PC在肿瘤致死原因中列第四位,是5年生存率最低的恶性肿瘤,而缺乏早期诊断手段 ...
刘书中 +3 more
doaj
[A Review of Metabolic Stress and Development of Pancreatic Cancer]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue Ban, 2021 Li JT, Lei MZ, Lei QY, Yin M.
europepmc +1 more source
Zhongguo shiyan zhenduanxue胰腺癌是一种侵袭性极强的恶性肿瘤，近年来全球范围内胰腺癌的发病率和死亡率呈快速上升趋势，并趋于年轻化[1]。中国胰腺癌发病率位居第10位，在癌症相关死因中位居第6位[2]。胰腺癌病情进展迅速，但是其起病隐匿，无特异症状。
doaj +2 more sources
Zhongguo shiyan zhenduanxue, 2002 目的 研究血清肿瘤标志物联合检测在胰腺癌诊治中的作用。方法 采用化学发光免疫法、荧光免疫法和放射免疫法对 12 9例胰腺癌患者的血清肿瘤标志物AFP、CEA、CA - 5 0、CA72 - 4、CA - 12 5、CA15 3、CA19- 9和CA2 4 2水平进行测定 ,并与 99例非胰腺恶性肿瘤及 6 3例良性疾病患者进行对比 ,分析其临床诊断价值。 2 7例胰腺癌根治术后还接受了连续监测。结果 8种肿瘤标志物中 ,CA19 9、CA2 4 2、CA - 5 0和CA72 ...
蒋晓婷
doaj
Research and guidelines interpretation of neoadjuvant therapy for resectable pancreatic cancer, promising or limited? [PDF]
As a systemic disease, pancreatic cancer is highly malignant and has a high rate of recurrence and metastasis, which makes it particularly difficult in diagnosis, treatment and management.
ZHANG Taiping, WENG Guihu, LIU Yueze
core +1 more source